Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
life sciences
national blog main
11
×
new york blog main
11
×
boston blog main
boston top stories
clinical trials
national top stories
new york top stories
boston
fda
cancer
san francisco blog main
startups
san francisco top stories
biogen
deals
europe blog main
ipo
national
novartis
san diego blog main
sanofi
venture capital
abbvie
allergan
alnylam pharmaceuticals
amgen
blackstone group
boulder/denver blog main
boulder/denver top stories
david goldstein
deerfield management
depression
detroit blog main
detroit top stories
drug discovery
epilepsy
essential tremor
europe top stories
What
medicines
11
×
new
ipo
drugs
fda
research
therapeutics
ago
aims
based
bio
biotechs
brings
ceo
class
covid
deal
developing
drug
emerged
experimental
genetic
ipos
pipeline
praxis
precision
roundup
years
acquire
acquisitions
activity
adding
adults
agreed
aiming
allergan
announced
approach
approvals
approved
Language
unset
11
×
Current search:
medicines
×
biotech
×
" national blog main "
×
" new york blog main "
×
unset
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further